News
Bayer: Life Sciences off to a good start in...
For the Bayer Group, the first quarter of 2013 was marked by the positive development of its Life Sciences businesses. "HealthCare and CropScience got...
News
Fighting bacteria with a new genre of antibodies
In an advance toward coping with bacteria that shrug off existing antibiotics and sterilization methods, scientists are reporting development of a new family of...
News
Drug reduces fat by blocking blood vessels
Researchers have long known that cancerous tumors grow collections of abnormal blood cells, the fuel that feeds this disease and keeps it growing. ...
News
Radioactive bacteria targets metastatic pancreatic cancer
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect...
News
Hundreds of alterations and potential drug targets to starve...
A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer. ...
News
Treatment for novel coronavirus shows promise in early lab...
National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b,...
News
Daiichi Sankyo and Ranbaxy launch hybrid business in Brazil...
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Ranbaxy Laboratories Limited (hereafter, Ranbaxy) today announced synergy in Brazil to expand the business of both...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.